Let’s Start this Interesting Article Shared on DesiNew.xyz
Currently, Phase III trials of AZD1222 in Brazil are being conducted on thousands of volunteers to understand the safety and efficacy of the vaccine candidate. On the other hand, the Serum Institute of India, the world’s largest vaccine manufacturer by volume, has produced 1 billion doses of the COVID vaccine in collaboration with UK drug manufacturer AstraZeneca.
SII CEO Adar Poonawalla told PTI, “Currently, we are working on the AstraZeneca Oxford vaccine, which is undergoing Phase III clinical trials. Apart from this, we will also start human trials in India in August 2020. Based on the most recent updates on current status and clinical trials, we are expecting the AstraZeneca Oxford vaccine to be available by the end of this year. “
STAY TUNED WITH US FOR MORE INTERESTING CONTENT ONLY ON DESINEW.XYZ